Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001829126-26-007603
Filing Date
2026-07-15
Accepted
2026-07-15 16:20:30
Documents
51
Period of Report
2026-05-31

Document Format Files

Seq Description Document Type Size
1 10-Q blackhawk_10q.htm   iXBRL 10-Q 580010
2 EXHIBIT 31.1 blackhawk_ex31-1.htm EX-31.1 14906
3 EXHIBIT 31.2 blackhawk_ex31-2.htm EX-31.2 14972
4 EXHIBIT 32.1 blackhawk_ex32-1.htm EX-32.1 6043
5 EXHIBIT 32.2 blackhawk_ex32-2.htm EX-32.2 6000
  Complete submission text file 0001829126-26-007603.txt   3546781

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bkhau-20260531.xsd EX-101.SCH 30739
7 XBRL CALCULATION FILE bkhau-20260531_cal.xml EX-101.CAL 28637
8 XBRL DEFINITION FILE bkhau-20260531_def.xml EX-101.DEF 133776
9 XBRL LABEL FILE bkhau-20260531_lab.xml EX-101.LAB 235956
10 XBRL PRESENTATION FILE bkhau-20260531_pre.xml EX-101.PRE 211856
54 EXTRACTED XBRL INSTANCE DOCUMENT blackhawk_10q_htm.xml XML 442901
Mailing Address 4125 BLACKHAWK PLAZA CIRCLE SUITE 166 DANVILLE CA 94506
Business Address 4125 BLACKHAWK PLAZA CIRCLE SUITE 166 DANVILLE CA 94506 203-520-7122
Black Hawk Acquisition Corp (Filer) CIK: 0002000775 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 001-41984 | Film No.: 261177600
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)